Quality of life after renal denervation

Hypertension

Volumn 61, Issue 4, 2013, Pages

  Persu, Alexandre ^a   Durand Zaleski, Isabelle ^b   Renkin, Jean ^a   Staessen, Jan A ^c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b FACULTÉ DE MÉDECINE   (France)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; FOLLOW UP; HEALTH SURVEY; KIDNEY DENERVATION; LETTER; MENTAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; SELF EVALUATION; SHORT FORM 36;

FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MENTAL HEALTH; QUALITY OF LIFE; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84875213600     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00908     Document Type: Letter

References (3)

1. Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, Shaw J, Krum H, Dixon JB, Barton DA, Schlaich MP. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension. 2012;60:1479-1484.
2. Persu A, Renkin J, Thijs L, Staessen JA. Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension. 2012;60:596-606.
3. Chen CE, Dhruva SS, Redberg RF. Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval. JAMA. 2012;308:1740-1742.